Original news and analysis on international IP policy
WASHINGTON, DC -- The sun may be setting on multilateral policymaking in intellectual property in the eyes of industry, but leading United States and European Union representatives insist on its continued vital role in trade and economy. But a “new narrative” is needed as they emphasise bilateral and plurilateral agreements.
A recent workshop on patentability criteria illustrated how countries are using the policy space provided by international trade rules to calibrate their patent law. In particular, incremental innovation remains a trying issue for national legislators, speakers said.
The European Union Council of ministers today adopted its position on the reform of the European trademark system. The Netherlands delegation abstained from voting out of concern that the proposed reform introduces the possibility to stop goods in transit for possible intellectual property infringement.
The mobile, satellite and broadcasting industries are campaigning for bigger shares of the finite resource that is radio-frequency spectrum at the UN International Telecommunication Union (ITU)’s treaty-making conference this month. And in an exhibition area alongside the conference, some of the world’s biggest tech companies are pitching their need for greater spectrum allocation in the hopes of influencing the conference’s outcomes. Among them is Facebook's Internet.org project.
The Medicines Patent Pool has announced the expansion of its mandate to cover hepatitis C and tuberculosis treatment. The MPP was previously concentrating only on HIV medicines.
The implementation of the UN World Intellectual Property Organization Development Agenda ranked high in the opening statements of developing country delegates attending this week’s Committee on Development and Intellectual Property. The participation of WIPO in the broader UN Sustainable Development Goals was also raised.
The World Intellectual Property Organization Committee on Development and Intellectual Property (CDIP) meets this week with a full agenda, including guides on trademark licensing, open innovation networks, and IP commercialisation. Delegates are expected to approve new development project proposals and progress reports on existing projects. Also on the agenda is the spicy issue of coordination of the WIPO Development Agenda.
Last week's decision by a World Trade Organization committee to allow least-developed countries to not apply global IP rules for pharmaceuticals for 17 more years made WTO members accountable to humanity, the coordinator of the LDC Group has said. Pharmaceuticals are different from all other forms of IP, he said.
The TPP is done, or not quite. But what is still lacking, what are next steps and what does the finalised deal do to the grand picture of the mega-trade deal landscape? Japanese economist Nakagawa Junji, Professor of International Economic Law Institute of Social Science, University of Tokyo, shares a view from Japan with writer Monika Ermert.
After two weeks of high level negotiations between the United States and the Group of Least-Developed Countries, the World Trade Organization committee on intellectual property rights today agreed to extend a waiver allowing LDCs to avoid applying and enforcing IP rights on pharmaceutical products until 2033.
October saw a flurry of changes in law offices in the United States. In Geneva, the coordination for Group B developed countries at the World Intellectual Property Organization changed hands, and the Medicines Patent Pool added four members to its Governance Board.
Four weeks after the finalisation of the agreement, the final text of the Trans-Pacific Partnership (TPP) was finally released by the United States and other partners of the first of the regional mega-trade deals. The parties hurried to underline the success of the negotiations, but early reactions were deeply divided.